{"id":35053,"date":"2017-02-03T05:34:03","date_gmt":"2017-02-03T10:34:03","guid":{"rendered":"http:\/\/livingston-new.dev\/non-classifiee\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/"},"modified":"2017-02-06T06:07:07","modified_gmt":"2017-02-06T11:07:07","slug":"government-canada-seeks-views-record-discussion-trade-pharmaceutical-products","status":"publish","type":"post","link":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/","title":{"rendered":"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques"},"content":{"rendered":"

Affaires mondiales a r\u00e9cemment annonc\u00e9 que le gouvernement du Canada sollicite les vues des Canadiens sur un cinqui\u00e8me examen propos\u00e9 du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques de 1994 (l\u2019\u00ab entente \u00bb) conclu entre les membres suivants de l\u2019Organisation mondiale du commerce (OMC) : le Canada, l\u2019Union europ\u00e9enne, le Japon, Macao (Chine), la Norv\u00e8ge, la Suisse et les \u00c9tats-Unis.<\/p>\n

L\u2019entente actuelle vise pr\u00e8s de 9\u2009000 produits pharmaceutiques. Cependant, il a \u00e9t\u00e9 sugg\u00e9r\u00e9 d\u2019\u00e9largir sa port\u00e9e afin d\u2019inclure d\u2019autres compos\u00e9s publi\u00e9s par l\u2019Organisation mondiale de la sant\u00e9 (OMS) en tant que d\u00e9nominations communes internationales propos\u00e9es<\/a>.<\/p>\n

Le gouvernement du Canada cherche \u00e0 d\u00e9finir les int\u00e9r\u00eats des Canadiens en ce qui a trait aux produits vis\u00e9s ainsi que toute pr\u00e9occupation concernant l\u2019\u00e9limination propos\u00e9e des droits de douane canadiens pour ces produits. \u00c0 cette fin, le gouvernement entreprend un processus de consultation publique afin de donner \u00e0 toutes les parties int\u00e9ress\u00e9es l\u2019occasion de faire part de leurs commentaires. Les parties qui souhaitent contribuer \u00e0 ce processus sont invit\u00e9es \u00e0 r\u00e9pondre aux trois questions suivantes :<\/p>\n

    \n
  1. Appuyez-vous le cinqui\u00e8me examen propos\u00e9 des produits vis\u00e9s par le Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques ? Veuillez justifier votre r\u00e9ponse.<\/li>\n
  2. Devez-vous faire face \u00e0 des entraves tarifaires dans les pays participants en ce qui concerne les exportations d\u2019ingr\u00e9dients pharmaceutiques ou de produits interm\u00e9diaires ? Dans l\u2019affirmative, sont-elles li\u00e9es \u00e0 des ingr\u00e9dients pharmaceutiques ou \u00e0 des produits interm\u00e9diaires particuliers? Veuillez fournir les codes de souspositions correspondantes du Syst\u00e8me harmonis\u00e9 (SH).<\/li>\n
  3. Avez-vous des opinions sur l\u2019\u00e9limination des droits d\u2019importation canadiens sur les ingr\u00e9dients pharmaceutiques et les produits interm\u00e9diaires \u00e9num\u00e9r\u00e9s par l\u2019OMS ? Dans l\u2019affirmative, veuillez fournir une description des ingr\u00e9dients ou des produits interm\u00e9diaires et de leurs codes de sous-positions correspondantes du SH.<\/li>\n<\/ol>\n

    La date limite pour recevoir les commentaires est le 10 mars 2017. Veuillez noter que toute information re\u00e7ue \u00e0 la suite de cette consultation sera consid\u00e9r\u00e9e comme information publique, sauf si elle est explicitement d\u00e9sign\u00e9e comme information priv\u00e9e. Les soumissions doivent inclure le nom et l\u2019adresse du contributeur et, le cas \u00e9ch\u00e9ant, son organisation, institution ou entreprise.<\/p>\n

    Des informations suppl\u00e9mentaires concernant le Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques sont fournies sur le site de l\u2019OMC<\/a>.<\/p>\n

    Les questions et les contributions peuvent \u00eatre envoy\u00e9es par la poste ou par courriel \u00e0 l\u2019adresse suivante : Initiative pharmaceutique de l\u2019OMC, Direction des droits de douane et de l\u2019acc\u00e8s aux march\u00e9s des marchandises (TPG), Affaires mondiales Canada, 111, promenade Sussex, Ottawa (Ontario) K1A 0G2 ; courriel : tpg@international.gc.ca<\/a>.<\/p>\n

    Les questions ou commentaires concernant les tarifs canadiens doivent \u00eatre envoy\u00e9s par la poste ou par courriel \u00e0 l\u2019adresse suivante : Initiative pharmaceutique de l\u2019OMC, Direction de la politique commerciale internationale, Minist\u00e8re des Finances, 90, rue Elgin, 14e \u00e9tage, Ottawa (Ontario) K1A 0G5 ; courriel : fin.tariff-tarif.fin@canada.ca<\/a>.<\/p>\n

    L\u2019article complet est \u00e9galement publi\u00e9 dans le vol. 150, no 52 de la Gazette du Canada<\/a>.<\/p>\n","protected":false},"excerpt":{"rendered":"

    Affaires mondiales a r\u00e9cemment annonc\u00e9 que le gouvernement du Canada sollicite les vues des Canadiens sur un cinqui\u00e8me examen propos\u00e9 du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques de 1994 (l\u2019\u00ab entente \u00bb) conclu entre les membres suivants de l\u2019Organisation mondiale du commerce (OMC) : le Canada, l\u2019Union europ\u00e9enne, le Japon, Macao… Read more »<\/a><\/p>\n","protected":false},"author":36,"featured_media":35051,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[174],"class_list":["post-35053","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-nouvelles-de-la-reglementation-canadienne"],"acf":[],"yoast_head":"\nLe Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques - Livingston International<\/title>\n<meta name=\"robots\" content=\"noindex, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<meta property=\"og:locale\" content=\"fr_FR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques - Livingston International\" \/>\n<meta property=\"og:description\" content=\"Affaires mondiales a r\u00e9cemment annonc\u00e9 que le gouvernement du Canada sollicite les vues des Canadiens sur un cinqui\u00e8me examen propos\u00e9 du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques de 1994 (l\u2019\u00ab entente \u00bb) conclu entre les membres suivants de l\u2019Organisation mondiale du commerce (OMC) : le Canada, l\u2019Union europ\u00e9enne, le Japon, Macao... Read more »\" \/>\n<meta property=\"og:url\" content=\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/\" \/>\n<meta property=\"og:site_name\" content=\"Livingston International\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/livingstoninternational\" \/>\n<meta property=\"article:published_time\" content=\"2017-02-03T10:34:03+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2017-02-06T11:07:07+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"800\" \/>\n\t<meta property=\"og:image:height\" content=\"533\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Dan Ovsey\" \/>\n<meta name=\"twitter:label1\" content=\"\u00c9crit par\" \/>\n\t<meta name=\"twitter:data1\" content=\"Dan Ovsey\" \/>\n\t<meta name=\"twitter:label2\" content=\"Dur\u00e9e de lecture estim\u00e9e\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/\"},\"author\":{\"name\":\"Dan Ovsey\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37\"},\"headline\":\"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques\",\"datePublished\":\"2017-02-03T10:34:03+00:00\",\"dateModified\":\"2017-02-06T11:07:07+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/\"},\"wordCount\":555,\"image\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg\",\"articleSection\":[\"Nouvelles de la r\u00e9glementation canadienne\"],\"inLanguage\":\"fr-FR\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/\",\"url\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/\",\"name\":\"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques - Livingston International\",\"isPartOf\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg\",\"datePublished\":\"2017-02-03T10:34:03+00:00\",\"dateModified\":\"2017-02-06T11:07:07+00:00\",\"author\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37\"},\"breadcrumb\":{\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#breadcrumb\"},\"inLanguage\":\"fr-FR\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#primaryimage\",\"url\":\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg\",\"contentUrl\":\"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg\",\"width\":800,\"height\":533},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Accueil\",\"item\":\"https:\/\/staging.livingstonintl.com\/fr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#website\",\"url\":\"https:\/\/staging.livingstonintl.com\/fr\/\",\"name\":\"Livingston International\",\"description\":\"Simplify Trade\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/staging.livingstonintl.com\/fr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"fr-FR\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37\",\"name\":\"Dan Ovsey\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"fr-FR\",\"@id\":\"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/7d812bb5d2ce09a8dbfe560c16be7b5260f689323f5b82727809faa3e53644ed?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/7d812bb5d2ce09a8dbfe560c16be7b5260f689323f5b82727809faa3e53644ed?s=96&d=mm&r=g\",\"caption\":\"Dan Ovsey\"},\"url\":\"https:\/\/staging.livingstonintl.com\/fr\/author\/dan-ovsey\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques - Livingston International","robots":{"index":"noindex","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"og_locale":"fr_FR","og_type":"article","og_title":"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques - Livingston International","og_description":"Affaires mondiales a r\u00e9cemment annonc\u00e9 que le gouvernement du Canada sollicite les vues des Canadiens sur un cinqui\u00e8me examen propos\u00e9 du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques de 1994 (l\u2019\u00ab entente \u00bb) conclu entre les membres suivants de l\u2019Organisation mondiale du commerce (OMC) : le Canada, l\u2019Union europ\u00e9enne, le Japon, Macao... Read more »","og_url":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/","og_site_name":"Livingston International","article_publisher":"https:\/\/www.facebook.com\/livingstoninternational","article_published_time":"2017-02-03T10:34:03+00:00","article_modified_time":"2017-02-06T11:07:07+00:00","og_image":[{"width":800,"height":533,"url":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg","type":"image\/jpeg"}],"author":"Dan Ovsey","twitter_misc":{"\u00c9crit par":"Dan Ovsey","Dur\u00e9e de lecture estim\u00e9e":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#article","isPartOf":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/"},"author":{"name":"Dan Ovsey","@id":"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37"},"headline":"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques","datePublished":"2017-02-03T10:34:03+00:00","dateModified":"2017-02-06T11:07:07+00:00","mainEntityOfPage":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/"},"wordCount":555,"image":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#primaryimage"},"thumbnailUrl":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg","articleSection":["Nouvelles de la r\u00e9glementation canadienne"],"inLanguage":"fr-FR"},{"@type":"WebPage","@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/","url":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/","name":"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques - Livingston International","isPartOf":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#primaryimage"},"image":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#primaryimage"},"thumbnailUrl":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg","datePublished":"2017-02-03T10:34:03+00:00","dateModified":"2017-02-06T11:07:07+00:00","author":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37"},"breadcrumb":{"@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#breadcrumb"},"inLanguage":"fr-FR","potentialAction":[{"@type":"ReadAction","target":["https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/"]}]},{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#primaryimage","url":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg","contentUrl":"https:\/\/lii-mkt-content.s3.amazonaws.com\/livingston-content\/uploads\/2017\/02\/25230150\/pharmaceutical.jpg","width":800,"height":533},{"@type":"BreadcrumbList","@id":"https:\/\/staging.livingstonintl.com\/fr\/government-canada-seeks-views-record-discussion-trade-pharmaceutical-products\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Accueil","item":"https:\/\/staging.livingstonintl.com\/fr\/"},{"@type":"ListItem","position":2,"name":"Le Gouvernement du Canada sollicite les vues \u00e0 propos du Compte rendu des d\u00e9bats sur le commerce des produits pharmaceutiques"}]},{"@type":"WebSite","@id":"https:\/\/staging.livingstonintl.com\/fr\/#website","url":"https:\/\/staging.livingstonintl.com\/fr\/","name":"Livingston International","description":"Simplify Trade","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/staging.livingstonintl.com\/fr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"fr-FR"},{"@type":"Person","@id":"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/41a41f5d824482db93829b4697ca9f37","name":"Dan Ovsey","image":{"@type":"ImageObject","inLanguage":"fr-FR","@id":"https:\/\/staging.livingstonintl.com\/fr\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/7d812bb5d2ce09a8dbfe560c16be7b5260f689323f5b82727809faa3e53644ed?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/7d812bb5d2ce09a8dbfe560c16be7b5260f689323f5b82727809faa3e53644ed?s=96&d=mm&r=g","caption":"Dan Ovsey"},"url":"https:\/\/staging.livingstonintl.com\/fr\/author\/dan-ovsey\/"}]}},"_links":{"self":[{"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/posts\/35053","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/users\/36"}],"replies":[{"embeddable":true,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/comments?post=35053"}],"version-history":[{"count":0,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/posts\/35053\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/media\/35051"}],"wp:attachment":[{"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/media?parent=35053"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/staging.livingstonintl.com\/fr\/wp-json\/wp\/v2\/categories?post=35053"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}